The science of cancer meets the power of metabolism
Cancer therapies have remained largely unchanged for decades. At Faeth, we believe that the use of metabolism and precision nutrition will join surgery, radiotherapy, small molecules (e.g. chemotherapy, targeted therapies), and biologics (e.g. immunotherapy, antibodies) as a foundational treatment for cancer.
Faeth is a data-driven, evidence-based company with a deep mechanistic understanding of the way that dietary nutrients influence tumor growth and cancer treatment. We are fully focused on matching specific diets with tumor genotypes and treatment regimens to improve the outcomes of cancer therapy, and we’re in clinical trials now.
Using metabolism and precision nutrition to starve cancer of the nutrients it needs to grow and resist treatment has the potential to transform the efficacy of conventional cancer therapies.
Our mission is to help every cancer patient use the power inside them to beat their cancer with world-leading science and precision nutrition.
Our team of world-leading scientists and founders
Anand Parikh, J.D.
CEO & Co-Founder
Former CFO at Virta Health
Oliver Maddocks, PhD
Head of Research, Co-Founder
Professor of Cancer Biology & Metabolism, University of Glasgow
Lew Cantley, PhD
Director Meyer Cancer Center, Weill Cornell Medicine, Founder: Agios (NASDAQ), Petra, Volastra
Greg Hannon, PhD
Director of CRUK Cambridge Institute
Scott Lowe, PhD
Chair of Cancer Biology & Genetics at Memorial Sloan Kettering, Founder: ORIC (NASDAQ)
Sid Mukherjee, MD PhD
Asst. Prof., Columbia, Pulitzer Prize Winner, Time 100 Most Influential People, Founder: Vor (NASDAQ)
Karen Vousden, PhD
Chief Scientist of CRUK, Group Leader, Crick Institute, Director, Bristol Myers Squibb
Marcus Goncalves, MD PhD
Asst. Prof., Endocrinology, Diabetes and Metabolism, Weill Cornell Medicine New York
Ben Hopkins, PhD
Asst. Prof., Genetics Genomics & Oncological Sciences, Icahn School of Medicine at Mount Sinai New York
Simon Knott, PhD
Asst. Prof., Biomedical Sciences & Associate Director, Center for Bioinformatics and Functional Genomics, Cedars Sinai Medical Center Los Angeles
Associate Director of Basic and Translational Research, UCLA Johnson Comprehensive Cancer Center; Professor of Biological Chemistry, David Geffen School of Medicine at UCLA; Co-Director, UCLA Metabolomics Center
Investigator, Howard Hughes Medical Institute; Chief of the Division of Genetics and Metabolism in the Department of Pediatrics, UT Southwestern Medical Center
Matthew Vander Heiden
Associate Professor of Biology, MIT; Associate Director, Koch Institute for Integrative Cancer Research